C4 Therapeutics (CCCC) Treasury Shares (2019 - 2026)

C4 Therapeutics' Treasury Shares history runs 7 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• In Q1 2026, Treasury Shares changed N/A year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (changed N/A YoY), while the FY2025 annual figure was $2.8 million, up 2776.28% from the prior year.
• Treasury Shares was $4.5 million for Q1 2026 at C4 Therapeutics, up from $2.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.5 million in Q1 2026 to a low of $6634.0 in Q3 2024.
• Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $687140.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 99.12% in 2024, then jumped 43183.48% in 2025.
• A 5-year view of Treasury Shares shows it stood at $468316.0 in 2022, then slumped by 67.12% to $154000.0 in 2023, then slumped by 36.36% to $98000.0 in 2024, then soared by 2776.28% to $2.8 million in 2025, then soared by 58.48% to $4.5 million in 2026.
• The last three Treasury Shares figures came in at $4.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.